Koninklijke DSM NV (RDSMY) Given Consensus Rating of “Buy” by Brokerages
Shares of Koninklijke DSM NV (OTCMKTS:RDSMY) have been assigned an average rating of “Buy” from the six ratings firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company.
RDSMY has been the subject of several research analyst reports. initiated coverage on shares of Koninklijke DSM in a report on Friday, September 1st. They issued a “buy” rating for the company. Zacks Investment Research lowered shares of Koninklijke DSM from a “buy” rating to a “hold” rating in a report on Tuesday, September 19th. Finally, Deutsche Bank raised shares of Koninklijke DSM from a “hold” rating to a “buy” rating in a research report on Friday.
Shares of Koninklijke DSM (OTCMKTS:RDSMY) traded up $0.08 during trading hours on Friday, hitting $23.49. The stock had a trading volume of 82,387 shares, compared to its average volume of 36,869. The firm has a market capitalization of $16,923.79, a P/E ratio of 29.15, a P/E/G ratio of 2.88 and a beta of 1.21. Koninklijke DSM has a 12 month low of $14.50 and a 12 month high of $23.36. The company has a current ratio of 1.74, a quick ratio of 1.11 and a debt-to-equity ratio of 0.44.
About Koninklijke DSM
Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company’s segments include Nutrition, Performance Materials, Innovation Center and Corporate Activities. Its Nutrition segment includes DSM Nutritional Products and DSM Food Specialties.
Receive News & Ratings for Koninklijke DSM NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM NV and related companies with MarketBeat.com's FREE daily email newsletter.